Australia Stock Exchange release from PARADIGM BIOPHAR : PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
02/11/2021 21:45
Australia Stock Exchange release from PARADIGM BIOPHAR PAR.AX : PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt